Although mechanical thrombectomy (MT) has been shown in numerous trials to be a successful treatment option for patients with large vessel occlusion (LVO), there is limited information on the safety and effectiveness of the technique in cases of recurrent LVO. To this end, we performed a retrospective review of our prospectively maintained database to identify all patients that had undergone more than one MT procedure January 2008 and January 2018. The data collected on these patients included baseline demographics and any history of diabetes mellitus, hypercholesterolaemia, hypertension, atrial fibrillation or smoking. We also recorded when the symptoms had started, the patient's NIHSS and ASPECT scores, the number of passes taken, the patient's final TICI score, any complications which arose and the patient's mRS at 90 days.
Introduction
The recent success of mechanical thrombectomy trials has led to a major change in the management of patients presenting with stroke [1] [2] [3] [4] [5] . The major trials published in 2015 established the superiority of mechanical thrombectomy over thrombolysis for proximal large vessel occlusion in the anterior circulation. There is now a growing body of evidence which could support the idea of making mechanical thrombectomy available to more patients than at present. This could include treating patients with lower NIHSS scores at admission [6] [7] [8] [9] , those with more distal occlusions [10] [11] [12] [13] [14] , patients with larger infarct volumes at presentation [15] , and patients presenting more than 6 h after the event [16, 17] .
Despite the wealth of data that has been obtained from the major trials and numerous case series, there remain unanswered questions including the safety and necessity of repeat thrombectomy. Previous studies have shown that repeat thrombolytic therapy is safe [18] [19] [20] [21] [22] , however, there is limited data on the safety of recurrent mechanical thrombectomy [23] [24] [25] [26] .
We report our experience of treating patients with recurrent LVO and discuss the underlying aetiology, the frequency of cases and the safety and efficacy of a repeat procedure.
Methods

Patient selection
From our prospectively maintained database we retrospectively selected all patients that met our inclusion criteria. These were defined as any patient with a recurrent thromboembolic occlusion on pre-operative imaging who had been admitted to our institution for mechanical thrombectomy between January 2008 and January 2018. 
Endovascular stroke therapy
The patients had been deemed to be suitable candidates for mechanical thrombectomy following consultation between the treating neurologist and the neurointerventionist. Mechanical thrombectomy was only offered if an acute occlusion could be seen on the pre-operative imaging and if salvageable brain tissue was thought to be present by the diagnostic and interventional neuroradiologists. Salvageable brain tissue was thought to be present if there was DWI/FLAIR mismatch on MRI [27] [28] [29] or if a hypoxic penumbra could be seen on CT perfusion. We do not select patients based on a set ratio of ischaemic core to hypoxic penumbra nor do we restrict mechanical thrombectomy to patients with an ASPECT score of greater than 6.
An upper age limit for performing mechanical thrombectomy does not exist in our institution; rather the pre-morbid status of the patient is taken into consideration along with co-morbidities and the wishes of the patient or family members. Similarly, we do not restrict mechanical thrombectomy based on time of onset.
All patients in the study underwent mechanical thrombectomy with stent-retrievers under general anaesthesia. There were two types of stent-receiver used; either Solitaire (Medtronic, Dublin, Ireland) or pRESet (phenox, Bochum, Germany). The decision as to which stent-retriever to use was initially based on access to the devices and later on operator preference.
Post-interventional management
All patients were admitted to either the neuro-intensive care or stroke unit after mechanical thrombectomy and had routine follow-up imaging with either CT or MRI 24-36 h post intervention. Follow-up assessment, including a modified Rankin Scale score (mRS), was obtained at 90 days through either an inpatient hospital visit or a telephone interview by a neurologist [30] . Patients were started on anti-platelet medication or anticoagulation in accordance with standard best practice after the initial thromboembolic stroke and in keeping with the likely underlying aetiology.
Data collection
Data collection included baseline demographics (age, sex), medical history (including any history of diabetes mellitus, hypercholesterolaemia, hypertension, atrial fibrillation), smoking history, and time of symptom onset and NIHSS to assess severity. The likely aetiology of the thromboembolic occlusion was based on the TOAST classification. The ASPECT score was calculated for all patients on axial CT or DWI MRI sequences. The number of passes needed to obtain the final result was also recorded. The final angiographic outcome was recorded using the Thrombolysis in Cerebral Infarction scale (TICI) [31] . Imaging was redone at 24-36 h after the intervention and both ASPECT score and the presence of any haemorrhaging was noted. Intra-cranial haemorrhage was classified according to the method used in the ECASS trials: parenchymal haematoma (PH-1, PH-2) and haemorrhagic infarction (HI-1, HI-2) [32] .
Results
Our dataset comprised 25 patients (of which 17 (68%) were female) who had undergone two or more mechanical thrombectomies in a total of 52 procedures. Seven of these patients received IV thrombolysis prior to mechanical thrombectomy using the standard dose of alteplase at 0.9 mg/kg. Two patients had three mechanical thrombectomy procedures. The average age at 1st presentation was 70 ± 12.8 years. The median time between one stroke and the next was 71 days (range 1-1059, IQR 183 days). One patient had a recurrent stroke 1 day after the initial stroke while three other patients had a recurrent stroke 7 days after the initial event.
Seventeen patients (68%) had a prior diagnosis of hypertension, 13 had been diagnosed with atrial fibrillation (52%), four patients had known diabetes mellitus (16%) while 2 patients (8%) had a positive history of smoking. The majority of the strokes were thought to have been caused by cardiac embolism (45/52, 86.5%). In one patient there was a history of intravenous drug abuse and endocarditic embolism was suspected. In another case there was massive dilated cardiomyopathy. In 5/52 events there was no definite cause while in one patient fibromuscular dysplasia was suspected as the cause for both events.
At the 1st presentation the median NIHSS score was 11.5 (range 1-24, IQR 6.75) (n = 23) and at the 2nd presentation was 10 (range 7-24, IQR 9) ( Table 1 ). There was no significant difference in the NIHSS score between the 1st and 2nd events (p = 0.552, Wilcoxon signed-rank test). The median ASPECT score at the 1st presentation was 8 (range, 6-10, IQR 1.5) (n = 21) and at the 2nd presentation was 8.5 (range, 5-10, IQR 2) (n = 24). The median time from onset to groin puncture was 220 mins (range 90-918, IQR 60.5) for the 1st procedure and 198 mins (range 58-673, IQR 123.75) for the second procedure (n = 20).
There was no significant difference in terms of the procedural time (70 ± 50mins vs. 77.8 ± 70.7mins, p = 0.62) or the number of device passes required (2 ± 1.6 vs. 2.2 ± 1.7, p = 0.34) to achieve adequate recanalization (TICI 2b-3). Adequate recanalization was achieved in 92% of patients (p = 0.90) in both the 1st and 2nd procedure (Table 2) .
There was a statistically significant difference between the number of patients that had a good clinical outcome (90 day mRS 2) and a poor clinical outcome (90 day mRS >3) after the 1st and 2nd strokes (p = 0.014) (Graph 1). The location of the 2nd stroke, in the ipsilateral or contralateral hemisphere to the 1st stroke, did not have a significant effect on the clinical outcome (n = 22, p = 0.66)
Complications
Patient number 6 had a small, non-flow limiting, ICA dissection following the 1st procedure and a localised asymptomatic subarachnoid haemorrhage after the 2nd procedure. Two patients also suffered from aspiration pneumonia in the post-operative period. The overall procedural and post-procedural complication rate was 7.7% (4/52).
Discussion
Mechanical thrombectomy has proven to be a revolutionary treatment for patients with thromboembolic stroke. However, despite the major breakthroughs that have been made in the last few years there remain numerous questions including the safety of repeat mechanical thrombectomy. To date, Bouslama et al [24] have published on this topic. In their series they identified 15 patients from 697 in their database (2%) that had suffered recurrent large vessel obstruction and undergone a mechanical thrombectomy procedure. The median time interval between the two procedures was 18 days (range 1-278). There was a significant difference in the NIHSS between the two procedures (15.9 ± 6.1 vs. 21.2 ± 7.2, p = 0.04) but no significant difference in other metrics such as time to puncture from last seen well. Successful reperfusion, defined as modified TICI !2b, was seen in 14/15 patients after the first procedure and 15/15 patients after repeat thrombectomy. They reported no vascular complications. There were no parenchymal haemorrhages noted after the first procedure but two were seen after the repeat procedure. Overall these results are similar to our own with no significant difference seen in the NIHSS at presentation, the operative times, or the final TICI scores. The rate of good clinical outcome (mRS 2) was 60% after the repeat thrombectomy with a 90-day mortality of 20%. It is worth noting however, that in the three patients that died, the 90-day outcome after the first procedure had been 4 in one patient and 5 in the second patient. In the third patient that died, it appears that the patient had had bilateral cardiac emboli separated by 24 h. This is perhaps to be expected since those patients with a poor outcome after the initial thrombectomy are likely to have had larger infarcts. It is also worth noting that all the patients that died had the second occlusion in the contralateral hemisphere and this too may play a role in the long-term outcome of patients given that the resulting damage will be bilateral. In our own series, and as would be expected, there was a statistically significant difference in the 90 day outcome for patients after 1st and 2nd strokes and by definition all the mRS 6 outcomes occurred after the 2nd event and at a remarkably similar rate (21.4%) to that seen by Bouslama et al. Although larger infarcts are associated with poorer clinical outcomes [33] [34] [35] recent studies have suggested that a significant proportion of patients with large infarcts (ASPECT <6) may still achieve a good clinical outcome. This should be borne in mind when considering patients for repeat mechanical thrombectomy and it seems reasonable to presume that if the overall size of the infarct -irrespective of when the damage has occurred -is likely to lead to a poor outcome, then preventing the infarct from expanding should be the aim. It is interesting to note that second strokes in a completely different territory, for example in the contralateral hemisphere, did not have a statistically significant effect on the outcome. We had suspected that LVO in a different arterial territory would result in a worse outcome and we believe that this is still likely to be the case. However, a larger sample size would be required to demonstrate this.
Two thirds of the cases reported by Bouslama et al were cardioembolic. In our data, close to 90% of the strokes were deemed as being cardioembolic in nature. The high frequency of cardioembolic strokes seems plausible given that in cases of intracranial or extracranial atherosclerosis, patients are likely to either undergo stenting or endarterectomy if suitable; either acutely or after the initial stroke as a preventative measure. However, treatment of heart arrhythmias and other cardioembolic sources of stroke can be more difficult. With the limited data available it seems reasonable to suggest aggressive management if cardioembolic stroke is suspected since this group seems the most at risk for a recurrent event.
Although numerous studies have shown endothelial damage after both stent-retriever thrombectomy and aspiration [36] [37] [38] [39] there is no evidence yet to support this damage being a cause of Table 2 Comparison between the NIHSS at presentation, the operative time and the final TICI score between the 1st and 2nd events.
Operative time TICI No of passes 90 day mRS
Patient no. 1st stroke 2nd stroke 3rd stroke 1st stroke 2nd stroke 3rd stroke 1st stroke 2nd stroke 3rd stroke 1st stroke 2nd stroke 3rd stroke 1 recurrent occlusion requiring repeat thrombectomy. In the elegant in vitro work of Teng et al. [36] , significant endothelial denudation was seen in association with the use of stent-retrievers which appeared to be principally due to the dragging of the stent through the vessel. Endothelial denudation was also seen in relation to aspiration catheters but this was less prominent than the injury seen with stent-retrievers. The consequences of this endothelial damage appear minimal, however, further research is required. Gory et al [39] used a swine model to test 5 different devices. They showed that both stent-retrievers and aspiration devices caused intimal damage as well as medial oedema. The latter was more pronounced with the aspiration devices. Stenosis has been shown to occur in vessels that have undergone mechanical thrombectomy, however, these were all asymptomatic [40] . Similarly, high resolution MR imaging of the arterial wall has shown complete resolution of signal abnormalities within 1 week [41] . Whilst the development of devices and techniques that minimize vascular trauma should be the goal there is currently no evidence to suggest the trauma caused by the commonly used devices has long-lasting implications. Although several of our retreatments occurred relatively soon after the 1st thrombectomy, we do not believe this was due to the procedure as there was no evidence of vessel injury on the final angiographic runs. The use of IV thrombolysis is generally contraindicated in patients with a history of stroke within the last 3 months because of the presumed increased risk of intracranial haemorrhage. This is thought to be particularly relevant in early recurrent strokes although a small series has shown that repeated IV thrombolysis can be safely and effectively given in selected patients [18] . Behme et al. have suggested that repeat thrombectomy may result in greater disruption of the vascular endothelium, thereby increasing the risk of complications such as vasospasm, arterial dissection, as well as intracranial hemorrhage [42] . Intravenous thrombolysis may promote blood brain barrier disruption and neurotoxicity, and this may increase the risk of haemorrhage [43] . The combined effect of anti-platelet agents and thrombolysis may increase the risk of haemorrhage with the second event and a direct mechanical thrombectomy could be considered. We do not believe there are significant increased risks especially if the period between the 1st and 2nd strokes is longer than 7 days. In our own series there was only a single small subarachnoid haemorrhage and in this particular patient the second event occurred in the contralateral hemisphere. However, we are uncertain of the relative increased risk in patients that present with very acute repeat LVO within the same territory.
Almost 1 in 4 patients will have a recurrent stroke within the first 5 years following acute ischaemic stroke [44] . In our own study the median time to second stroke was 71 days. Given that large vessel occlusion accounts for approximately 10-15% of all strokes there is a need to understand which patients are most at risk of suffering a recurrent large vessel stroke and to accordingly dedicate the appropriate resources to preventative measures. It is also necessary to determine if the safety profile of recurrent thrombectomy is acceptable. Even though the number of people undergoing repeat thrombectomy appears to be relatively small, it is likely that this is actually an under-representation of the true figure. There is a chance that small emboli could affect territory that has previously been infarcted and so may go unnoticed. Similarly, delays in diagnosis and/or mis-diagnosis are almost certain to occur and may also result in an under-representation of the true incidence of recurrent large vessel occlusion and hence recurrent thrombectomy Our study is limited by its retrospective design and small number of patients. Similarly, as we primarily use stent-retrievers to perform mechanical thrombectomy we are uncertain as to whether these results can be extrapolated to the use of aspiration as a primary method of recanalization. Furthermore, although our population is relatively diverse, the underlying cause of large vessel occlusion is likely to affect the chance of recurrent stroke and this will be different amongst different populations.
Conclusion
Repeat mechanical thrombectomy appears to be safe and technically feasible with cardioembolic stroke accounting for the majority of repeat large vessel occlusions. Preventative efforts should focus on minimising the need to preform repeat thrombectomy.
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